Leggett & Platt (LEG) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
7 Apr, 2026Executive summary
Annual meeting scheduled for May 21, 2026, with voting open until May 20, 2026, 11:59 PM ET.
Shareholders can access proxy materials online or request paper/email copies by May 7, 2026.
Meeting will be held virtually, with registration details provided in the proxy statement.
Voting matters and shareholder proposals
Election of eight directors: Angela Barbee, Robert E. Brunner, Mary Campbell, Karl G. Glassman, Joseph W. McClanathan, Srikanth Padmanabhan, Jai Shah, and Phoebe A. Wood.
Ratification of PricewaterhouseCoopers LLP as independent auditor for the year ending December 31, 2026.
Advisory vote on named executive officer compensation (say-on-pay).
Approval of amendment and restatement of the Flexible Stock Plan.
Other business may be addressed as appropriate during the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals.
Nominees represent a mix of experience and backgrounds.
Latest events from Leggett & Platt
- $2.5B all-stock acquisition expands global reach and targets $50M in annual synergies.LEG
M&A announcement14 Apr 2026 - Shareholders will vote virtually on directors, auditor, compensation, and stock plan amendments.LEG
Proxy filing7 Apr 2026 - Virtual annual meeting to vote on directors, auditor, executive pay, and stock plan amendments.LEG
Proxy filing7 Apr 2026 - Disciplined restructuring and innovation drive margin improvement and cash flow amid market headwinds.LEG
Investor presentation10 Mar 2026 - 2026 outlook: flat-to-down sales, margin gains, and focus on debt reduction amid weak demand.LEG
Q4 202512 Feb 2026 - Q2 loss driven by $675M impairment, lower sales, and restructuring; dividend cut for deleveraging.LEG
Q2 20242 Feb 2026 - Sales and earnings fell, guidance cut, and restructuring, impairment, and deleveraging continue.LEG
Q3 202418 Jan 2026 - Adjusted EPS up to $0.24 despite 7% sales drop; 2025 outlook and deleveraging focus maintained.LEG
Q1 202527 Dec 2025 - Restructuring and cost actions drive margin gains amid weak demand and a cautious 2025 outlook.LEG
Q4 202423 Dec 2025